JM
Josh Mesfin
Postdoctoral Scientist
Parabolis
Work experience
Postdoctoral Scientist
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Expertise
BioinformaticsCardiovascularImmunohistochemistryMicrofluidicsMolecular MedicineNanomaterials
Last updated Mar 2025
MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas
Sign up to view the full profile.
Explore areas of focus, current work, and collaboration capabilities.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.